CERE
Cerevel Therapeutics Holdings, Inc.
Director Deval L Patrick sold $753K of Cerevel Therapeutics Holdings, Inc.
Sold$753,250
$25.00Price
30,130Shares
−90%Stake
What CERE did after the filing
- The stock from Mon, Nov 6 open, $26.45
- +56.7%
- S&P 500, same days
- +9.5%
Measured over 30 trading days, to the Dec 19 close.
Traded Wed, Nov 1. Filed Fri, Nov 3, 4:15 PM ET, after the close. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.